ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 157,24
-0,91%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. XOMA Corporation (XOMA)

  7. XOMA Corporation (XOMA) Actualités

XOMA XOMA Corporation

25,41
0,05 (0,20%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
XOMA Corporation XOMA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,05 0,20% 25,41 23:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
25,08 25,08 25,4972 25,41 25,36
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202413:30GLOBEXOMA Earns $9 Million Milestone as FDA Grants Accelerated..
24/4/202415:00PRNUSActym Therapeutics Appoints Thomas Smart as CEO
03/4/202415:00GLOBEXOMA Corporation Announces Closing of Tender Offer
21/3/202412:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
19/3/202421:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
08/3/202413:30GLOBEXOMA Reports Fourth Quarter and Full Year 2023 Financial..
28/2/202413:30GLOBEXOMA to Present at Upcoming Investor Conferences in March
16/2/202414:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
18/1/202414:30GLOBEXOMA Expands its Commercial Royalty and Milestone Portfolio..
11/1/202422:50DJNXoma to Make $1 Million Milestone Payment to LadRx After FDA..
11/1/202422:05GLOBEFDA Acceptance of Zevra’s Arimoclomol NDA Filing for..
08/1/202413:30GLOBEXOMA Names Owen Hughes as Chief Executive Officer and..
02/1/202413:30GLOBEXOMA Announces Stock Repurchase Program of up to $50 Million
20/12/202313:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
19/12/202313:30GLOBEXOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse..
07/11/202313:30GLOBEXOMA Reports Third Quarter 2023 Financial Results and..
31/10/202312:30GLOBEXOMA Earns $5 Million Milestone Upon FDA Acceptance of Day..
25/9/202313:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
06/9/202313:30GLOBEXOMA to Present at H.C. Wainwright 25th Annual Global..
08/8/202313:30GLOBEXOMA Reports Second Quarter 2023 Financial Results and..
24/6/202300:14GLOBEXOMA Added to the Russell 2000® and Russell 3000® Indexes
22/6/202313:30GLOBEXOMA Acquires Royalty and Milestone Economics to Phase 3..
20/6/202313:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
09/5/202313:30GLOBEXOMA Reports First Quarter 2023 Financial Results and..

Dernières Valeurs Consultées

NASDAQ
XOMA
XOMA
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés